Insider Trading & Ownership - Higgons John Duncan

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Higgons John Duncan
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-04-15
Sale
2021-04-16
8:46 pm
Jounce Therapeutics Inc. JNCE Higgons John Duncan
Director
200 $10 $2,000 9,713
(Direct)
View
2021-03-15
Sale
2021-03-17
9:15 pm
Jounce Therapeutics Inc. JNCE Higgons John Duncan
Director
200 $12.8 $2,560 9,913
(Direct)
View
2021-02-16
Sale
2021-02-18
7:47 pm
Jounce Therapeutics Inc. JNCE Higgons John Duncan
Director
200 $11.78 $2,356 10,113
(Direct)
View
2021-01-20
Sale
2021-01-22
6:39 pm
Jounce Therapeutics Inc. JNCE Higgons John Duncan
Director
1,700 $11.9 $20,222 10,313
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-06-24
Option Award
2022-06-28
9:03 pm
N/A
2032-06-24
Jounce Therapeutics Inc. JNCE Higgons John Duncan
Director
20,000 $0 20,000
(Direct)
View
2021-06-18
Option Award
2021-06-22
4:46 pm
N/A
2031-06-18
Jounce Therapeutics Inc. JNCE Higgons John Duncan
Director
15,700 $0 15,700
(Direct)
View
2020-06-26
Option Award(A)
2020-07-02
7:34 pm
N/A
2030-06-26
Jounce Therapeutics Inc. JNCE Higgons John Duncan
Director
15,700 $0 15,700
(Direct)
View
2020-06-26
Option Award
2020-06-29
7:31 pm
N/A
2030-06-26
Jounce Therapeutics Inc. JNCE Higgons John Duncan
Director
13,550 $0 13,550
(Direct)
View
(A) Indicate amendment filing.